1. Evaluating of Red Blood Cell Distribution Width, Comorbidities and Electrocardiographic Ratios as Predictors of Prognosis in Patients with Pulmonary Hypertension
   Mario E. Baltazares-Lipp et al, 2021, Diagnostics CrossRef
2. lncRNA HIT000218960 enhances resistance to 5‑fluorouracil by promoting HMGA2 and activating the AKT/mTOR/P70S6K pathway in gastric cancer cells
   Li Bai et al, 2022, Experimental and Therapeutic Medicine CrossRef
3. Wound Healing Potential of Spirulina Protein on CCD-986sk Cells
   Ping Liu et al, 2019, Marine Drugs CrossRef
4. Genetic Delivery and Gene Therapy in Pulmonary Hypertension
   Nabham Rai et al, 2021, International Journal of Molecular Sciences CrossRef
5. Cellular mechanosignaling in pulmonary arterial hypertension
   Ariel Wang et al, 2021, Biophysical Reviews CrossRef
6. Elabela prevents angiotensin II-induced apoptosis and inflammation in rat aortic adventitial fibroblasts via the activation of FGF21–ACE2 signaling
   Juan-Juan Song et al, 2021, Journal of Molecular Histology CrossRef
7. In Vitro Assays Used to Analyse Vascular Cell Functions
   Adrian Türkcan et al, 2019, Fundamentals of Vascular Biology CrossRef
8. TRPV4 channel mediates adventitial fibroblast activation and adventitial remodeling in pulmonary hypertension
   Laure-Anne Cussac et al, 2020, American Journal of Physiology-Lung Cellular and Molecular Physiology CrossRef
9. A Mechanistic Exploratory Study on the Therapeutic Efficacy of Astragaloside IV Against Diabetic Retinopathy Revealed by Network Pharmacology
   Zhi-Hao Zhao et al, 2022, Frontiers in Pharmacology CrossRef